Abrams M - Search Results

1

Neurophysiologic predictors of treatment response to fluoxetine in major depression.

Cook IA, Leuchter AF, Witte E, Abrams M, Uijtdehaage SH, Stubbeman W, Rosenberg-Thompson S, Anderson-Hanley C, Dunkin JJ. Cook IA, et al. Among authors: abrams m. Psychiatry Res. 1999 Mar 22;85(3):263-73. doi: 10.1016/s0165-1781(99)00010-4. Psychiatry Res. 1999. PMID: 10333379 Clinical Trial.

2

Prospective testing of a neurophysiologic biomarker for treatment decisions in major depressive disorder: The PRISE-MD trial.

Cook IA, Hunter AM, Caudill MM, Abrams MJ, Leuchter AF. Cook IA, et al. Among authors: abrams mj. J Psychiatr Res. 2020 May;124:159-165. doi: 10.1016/j.jpsychires.2020.02.028. Epub 2020 Feb 26. J Psychiatr Res. 2020. PMID: 32169689 Free PMC article.

3

Changes in brain function of depressed subjects during treatment with placebo.

Leuchter AF, Cook IA, Witte EA, Morgan M, Abrams M. Leuchter AF, et al. Among authors: abrams m. Am J Psychiatry. 2002 Jan;159(1):122-9. doi: 10.1176/appi.ajp.159.1.122. Am J Psychiatry. 2002. PMID: 11772700 Clinical Trial.

4

Early changes in prefrontal activity characterize clinical responders to antidepressants.

Cook IA, Leuchter AF, Morgan M, Witte E, Stubbeman WF, Abrams M, Rosenberg S, Uijtdehaage SH. Cook IA, et al. Among authors: abrams m. Neuropsychopharmacology. 2002 Jul;27(1):120-31. doi: 10.1016/S0893-133X(02)00294-4. Neuropsychopharmacology. 2002. PMID: 12062912 Clinical Trial.

5

Pretreatment neurophysiological and clinical characteristics of placebo responders in treatment trials for major depression.

Leuchter AF, Morgan M, Cook IA, Dunkin J, Abrams M, Witte E. Leuchter AF, et al. Among authors: abrams m. Psychopharmacology (Berl). 2004 Dec;177(1-2):15-22. doi: 10.1007/s00213-004-1919-2. Epub 2004 Jul 14. Psychopharmacology (Berl). 2004. PMID: 15252704 Clinical Trial.

6

Subject expectations of treatment effectiveness and outcome of treatment with an experimental antidepressant.

Krell HV, Leuchter AF, Morgan M, Cook IA, Abrams M. Krell HV, et al. Among authors: abrams m. J Clin Psychiatry. 2004 Sep;65(9):1174-9. doi: 10.4088/jcp.v65n0904. J Clin Psychiatry. 2004. PMID: 15367043 Clinical Trial.

7

Changes in prefrontal activity characterize clinical response in SSRI nonresponders: a pilot study.

Cook IA, Leuchter AF, Morgan ML, Stubbeman W, Siegman B, Abrams M. Cook IA, et al. Among authors: abrams m. J Psychiatr Res. 2005 Sep;39(5):461-6. doi: 10.1016/j.jpsychires.2004.12.002. J Psychiatr Res. 2005. PMID: 15992554 Clinical Trial.

8

Midline and right frontal brain function as a physiologic biomarker of remission in major depression.

Cook IA, Hunter AM, Abrams M, Siegman B, Leuchter AF. Cook IA, et al. Among authors: abrams m. Psychiatry Res. 2009 Nov 30;174(2):152-7. doi: 10.1016/j.pscychresns.2009.04.011. Epub 2009 Oct 22. Psychiatry Res. 2009. PMID: 19853417 Free PMC article. Clinical Trial.

9

Neurophysiologic effects of repeated exposure to antidepressant medication: are brain functional changes during antidepressant administration influenced by learning processes?

Hunter AM, Cook IA, Abrams M, Leuchter AF. Hunter AM, et al. Among authors: abrams m. Med Hypotheses. 2013 Dec;81(6):1004-11. doi: 10.1016/j.mehy.2013.09.016. Epub 2013 Sep 17. Med Hypotheses. 2013. PMID: 24112999 Clinical Trial.

10

Brain structure and function and the outcomes of treatment for depression.

Leuchter AF, Cook IA, Uijtdehaage SH, Dunkin J, Lufkin RB, Anderson-Hanley C, Abrams M, Rosenberg-Thompson S, O'Hara R, Simon SL, Osato S, Babaie A. Leuchter AF, et al. Among authors: abrams m. J Clin Psychiatry. 1997;58 Suppl 16:22-31. J Clin Psychiatry. 1997. PMID: 9430506 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

621 results

Search Page

Filters